Furthermore, decreased desmin might be involved in the pathogenesis of DMD-associated DCM, whereas increased desmin in Δ3–9 hiPSC-CMs might compensate for the impaired function of internally truncated dystrophin, which might partially explain the reduced severity in the phenotype of DCM in Δ3–9 patients. Here, DES is linked to Duchenne muscular dystrophy.